ストックスクリーナーアプリを入手
5.15
9.34%
0.44
アフターアワーズ：
5.14
-0.01
-0.19%
前日終値:
$4.71
開ける：
$4.72
24時間の取引高:
77,361
Relative Volume:
0.98
時価総額：
$90.83M
収益：
$52.55M
当期純損益:
$-23.69M
株価収益率:
-2.5495
EPS:
-2.02
ネットキャッシュフロー:
$-15.29M
1週間 パフォーマンス:
-10.82%
1か月 パフォーマンス:
+22.62%
6か月 パフォーマンス:
+162.76%
1年 パフォーマンス:
+190.96%
1日の値動き範囲:
$4.72
$5.18
1週間の範囲:
$4.71
$6.22
52週間の値動き範囲:
$1.3003
$6.22
Exagen Inc Stock (XGN) Company Profile
XGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
5.15 | 90.83M | 52.55M | -23.69M | -15.29M | -1.34 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-04-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cowen | Outperform |
| 2019-10-14 | 開始されました | William Blair | Outperform |
すべてを表示
Exagen Inc (XGN) 最新ニュース
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD - GlobeNewswire
Exagen Hits Major Milestone: 1 Million AVISE Tests Revolutionize Autoimmune Disease Diagnosis - StockTitan
Exagen stock soars to 52-week high, hits $4.97 - Investing.com
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com India
Exagen stock soars to 52-week high, hits $4.88 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $4.88 amid robust gains - Investing.com Canada
Wasatch Advisors LP Sells 272,054 Shares of Exagen Inc. (NASDAQ:XGN) - MarketBeat
Exagen stock holds Sector Weight amid mixed 3Q24 results By Investing.com - Investing.com Nigeria
Exagen stock soars to 52-week high, hits $3.79 By Investing.com - Investing.com Canada
Exagen CEO, President & Director Acquires 7.7% More Stock - Simply Wall St
Exagen stock soars to 52-week high, hits $3.79 - Investing.com India
Exagen CFO Jeffrey Black acquires $66,448 in common stock - Investing.com India
Exagen CFO Jeffrey Black acquires $66,448 in common stock By Investing.com - Investing.com UK
Exagen president and CEO John Aballi buys $68,297 in stock By Investing.com - Investing.com Canada
Exagen president and CEO John Aballi buys $68,297 in stock - Investing.com
What is William Blair’s Forecast for Exagen FY2024 Earnings? - Defense World
Research Analysts Issue Forecasts for Exagen FY2024 Earnings - MarketBeat
FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Exagen - Defense World
Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
William Blair Reiterates “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World
Exagen unveils new biomarkers to enhance autoimmune testing - Investing.com
Exagen Inc. Completes Validation and Regulatory Submission - GlobeNewswire
Exagen Enhances AVISE CTD Platform with 7 New Biomarkers for Autoimmune Disease Detection | XGN Stock News - StockTitan
Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Exagen Inc. to Participate in Fourth Quarter Investor Conferences - The Manila Times
Exagen CEO to Present at Three Major Healthcare Investor Conferences | XGN Stock News - StockTitan
Exagen (NASDAQ:XGN) Receives Outperform Rating from William Blair - MarketBeat
Exagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Ch - GuruFocus.com
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... - Yahoo Finance
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... By GuruFocus - Investing.com Canada
Exagen Inc. Reports Q3 2024 Financial Results - TipRanks
Exagen Inc. (XGN) Quarterly 10-Q Report - Quartzy
Exagen stock holds Sector Weight amid mixed 3Q24 results - Investing.com
Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates - MSN
Exagen Inc (XGN) Q3 2024 Earnings: Revenue Misses Estimates at $12.5M, Net Loss Narrows to $5.0M - GuruFocus.com
Exagen Inc. Reports Third Quarter 2024 Results - GlobeNewswire
Exagen Q3 Revenue Hits $12.5M Despite Setbacks; YTD Performance Shows 37% Loss Reduction | XGN Stock News - StockTitan
Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect - GuruFocus.com
Exagen (XGN) to Release Earnings on Tuesday - Defense World
Exagen to Announce Third Quarter 2024 Results on November 12, 2024 - GlobeNewswire
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - The Manila Times
Exagen Inc (XGN) 財務データ
収益
当期純利益
現金流量
EPS
Exagen Inc (XGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
| ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
0.72%
大文字化:
|
ボリューム (24 時間):